New Feature: See every earnings report in one clear view

AEON Biopharma Inc

Contributing Author

Recent Articles by AEON Biopharma Inc

Aug-12	AEON Biopharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update AEON GlobeNewswire
Aug-03	AEON Biopharma Regains Compliance with NYSE American Continued Listing Standards AEON GlobeNewswire
Jul-14	AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding AEON +10.84% GlobeNewswire
Jun-04	AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX at the 68th Annual Scientific Meeting of the American Headache Society AEON GlobeNewswire
May-14	AEON Biopharma Reports First Quarter 2026 Financial Results and Provides Corporate Update AEON AEON -9.91% GlobeNewswire
Apr-24	AEON Biopharma Sets Annual Shareholder Meeting AEON GlobeNewswire
Apr-03	AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 AEON GlobeNewswire
Apr-03	AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards AEON GlobeNewswire
Mar-30	AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program AEON -14.70% GlobeNewswire
Mar-25	AEON Biopharma Announces FDA Feedback Following BPD Type 2a Meeting for the ABP-450 Biosimilar Program AEON GlobeNewswire
Mar-09	AEON Biopharma Appoints John Bencich as Chief Financial Officer AEON AEON +7.48% GlobeNewswire
Mar-05	AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting AEON -5.50% GlobeNewswire
Jan-21	AEON Biopharma Reports BPD Type 2a Meeting with FDA and Shareholder Approval of the November Transactions AEON +13.33% AEON -13.97% GlobeNewswire
Dec-19	AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 AEON +6.93% GlobeNewswire
Dec-15	AEON Biopharma Announces Execution of Exchange Agreement with Daewoong AEON +5.10% AEON +19.21% GlobeNewswire
Nov-20	AEON Biopharma Announces First Closing of PIPE Investment and Provides Update on FDA Type 2a Meeting Scheduling AEON -12.79% GlobeNewswire
Nov-14	AEON Biopharma Reports Third Quarter 2025 Results, Including Positive ABP-450 Biosimilarity Data and Strategic Positioning for Continued Growth AEON GlobeNewswire

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)